BioSpace News Archive

Inovalon, a leading provider of cloud-based platforms empowering data-driven healthcare, announced separate 5-year agreements with two prominent post-acute care providers, Vibra Healthcare and Ernest Health.

StageZero Life Sciences Ltd. announces that it is restating its financial statements for the three and six months ended June 30, 2020, along with a corresponding restated management discussion and analysis, and will be delayed in filing its interim financial statements for the three and nine months ended September 30, 2020 pending an accounting review, along with the corresponding management discussion and analysis.

Wilburn Medical USA announces the availability of AccessBio’s CareStart COVID-19 rapid antigen tests in stock for Medical Providers. Here’s more on it.

BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended September 30, 2020 on Thursday, November 26, 2020. A presentation on the Company’s third quarter and year-to-date 2020 results by René Goehrum, BioSyent President and CEO, will also be available on the Company’s website on the date of release. About BioSyent Inc. Listed on the TSX Venture Exchange und

Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that members of management will participate in A.G.P.’s Virtual Healthcare Symposium on Thursday, November 19 th , 2020. The event will consist of 1-on-1 virtual investor meetings. Investors attending the conference virtually who are interested in meeting with C

Dr. Rakesh Jetly Appointed Chief Medical Officer Company Announces International Expansion of Clinical Trial Sites for Phase 2A Study into Psychedelic Treatments for PTSD in Veterans

Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced today that oral paclitaxel and encequidar (“oral paclitaxel”) data will be presen

Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, reported results for the three months ended September 30, 2020. During the three months ended September 30, 2020, the Company ea

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce the conclusion of and successful two-year follow-up results from the STITCH Study for its novel NOVOSTITCH Meniscal Repair Systems.

The National Foundation for Infectious Diseases will honor several individuals for their significant and lasting contributions to public health